Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.46 | 9.60 |
| PEG Ratio (TTM) | 0.74 | -0.14 |
| P/S Ratio (TTM) | 0.47 | 5.04 |
| P/B Ratio (TTM) | 0.92 | 17.62 |
| P/FCF Ratio (TTM) | 70.41 | 20.11 |
| Price to 5YR AVG Earnings Ratio | 82.50 | 25.62 |
| Price to 5YR AVG FCF Ratio | -314.76 | 13.49 |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.08% | 6.10% |
| ROE (TTM) | 11.31% | 55.50% |
| Net Profit Margin (TTM) | 5.55% | -165.99% |
| ROIC 5YR AVG | 4.57% | 5.00% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 23.21% | -16.82% | 33.52% |
| Revenue | 1.44% | 1.01% | 6.58% |
| Net Income | 23.04% | -20.77% | 35.55% |
| Cash Flow | -26.56% | -35.56% | 2,818.29% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.49 | 1.50 |
| Quick Ratio (TTM) | 1.73 | 1.26 |
| D/E Ratio (TTM) | 0.07 | 1.53 |
| Interest Coverage (TTM) | 9.18 | 10.38 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 3.07 | 4.95 |
| LTL to 5YR AVG FCF | -31.61 | 1.36 |
| Shares Outstanding Growth 5YR AVG | 10.56% | -0.15% |